APA

Maykov E. B., Yuricheva Y. A., Mironov N. Y., Sokolov S. F., Golitsyn S. P., Rozenshtraukh L. V. & Chazov E. I. (20150428). [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter]. : Terapevticheskii arkhiv.

Chicago

Maykov E B, Yuricheva Yu A, Mironov N Yu, Sokolov S F, Golitsyn S P, Rozenshtraukh L V and Chazov E I. 20150428. [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter]. : Terapevticheskii arkhiv.

Harvard

Maykov E. B., Yuricheva Y. A., Mironov N. Y., Sokolov S. F., Golitsyn S. P., Rozenshtraukh L. V. and Chazov E. I. (20150428). [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter]. : Terapevticheskii arkhiv.

MLA

Maykov E B, Yuricheva Yu A, Mironov N Yu, Sokolov S F, Golitsyn S P, Rozenshtraukh L V and Chazov E I. [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter]. : Terapevticheskii arkhiv. 20150428.